Natco Pharma Releases FY26 Business Responsibility and Sustainability Report

Natco Pharma Limited has published its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26. The report details the company's corporate identity, registered and corporate addresses, and contact information for queries. Natco Pharma operates in two main segments: Pharmaceuticals and Agrochemicals, with pharmaceuticals accounting for 100% of its turnover, primarily through Finished Dosage Forms (FDFs) and Active Pharmaceutical Ingredients (APIs). The company has 9 manufacturing units and 2 R&D centers across India and serves over 50 countries internationally. The report highlights employee statistics, including a total of 4144 permanent and other than permanent employees and 916 workers, with a focus on gender representation. It also details the turnover rate for permanent employees and workers over the past three financial years. The BRSR disclosures are made on a standalone basis and have received limited assurance from DNV Business Assurance India Private Limited.